Please login to the form below

Not currently logged in
Email:
Password:

regulatory

This page shows the latest regulatory news and features for those working in and with pharma, biotech and healthcare.

Labour party divided on Brexit ‘People’s Vote’

Labour party divided on Brexit ‘People’s Vote’

The main sticking points between the UK and the EU27 remain the Irish border question and future trade and regulatory alignments, with little more than six months until Brexit day, 29 ... For us, this is a very relevant question and if the regulatory

Latest news

More from news
Approximately 32 fully matching, plus 1,186 partially matching documents found.

Latest Intelligence

  • The European Medicines Agency: PRIME’d for access? The European Medicines Agency: PRIME’d for access?

    So how has it gone? Leela Barham looks not just at the EMAs report of the first two years but what it might mean for patient access beyond regulatory approval.

  • Cancer immunotherapy: What's on the horizon? Cancer immunotherapy: What's on the horizon?

    antigen receptor T-cell (CAR-T) therapies from Novartis and Gilead gained regulatory approval in 2017 for acute lymphoblastic leukaemia (ALL) and diffuse large B-cell lymphoma (DLBCL) after showing remarkable ... There are big advantages to this approach,

  • Cutting through the noise

    True creativity is not just applying gloss; it should come from blending a deep understanding of the learner, educational principles, content and the regulatory environment with a person-centric mindset and

  • Diversity and inclusion in the pharma industry Diversity and inclusion in the pharma industry

    Gender pay gap: not an equal paying ground. Regulatory driven though it may be, GPG reporting provides a snapshot  of gender diversity in pharma and biotech industries and across corporate UK. ... These figures obviously form part of a regulatory request

  • ‘How is your day?’ ‘How is your day?’

    These are the patients whose lives are improved, medical professionals, international and local patient organisations, regulatory agencies and manufacturers of plasma  protein products.

More from intelligence
Approximately 8 fully matching, plus 271 partially matching documents found.

Latest appointments

  • BMS appoints CCO, Stephen Davies joins Eisai and more BMS appoints CCO, Stephen Davies joins Eisai and more

    Davies will be responsible for leading the pharma group’s IT function for its Americas region, as well as the company’s global clinical and regulatory departments.

  • Weekly industry appointments Weekly industry appointments

    There, he is medicines development leader for adenosine deaminase deficiency (ADA-SCID) gene therapy Strimvelis – the first alternative medicine to stem cell transplant for the disease that’s bagged a regulatory

  • Building trust in our industry Building trust in our industry

    This suggests that, within regulatory constraints, there is a role for pharma to become trusted publishers of healthcare information.

  • Nabriva Therapeutics appoints chief medical officer Nabriva Therapeutics appoints chief medical officer

    She brings a track record of successful navigating the regulatory submission and approval process, as well as leading medical affairs activities and will be an invaluable member of our team as

  • Alexion Pharmaceuticals adds to its board Alexion Pharmaceuticals adds to its board

    She brings strong corporate governance and legal expertise, with a proven track records in global compliance, strategic planning, data privacy and regulatory matters.

More from appointments
Approximately 3 fully matching, plus 225 partially matching documents found.

Latest from PMHub

  • The gene therapy revolution

    In the last few years, we have seen treatment possibilities expand and, looking at the current pipeline of drugs heading in the direction of the regulatory bodies in the coming months

  • Nurturing the growth mindset: The need for ongoing professional development in strategic medical communications

    However, the pressure of an increasingly competitive environment, combined with more rigorous standards set by our clients and pharmaceutical industry regulatory bodies, mean that we need to focus on continuously

  • New ICMJE Guidelines and their Impact on Biotech

    Their top management is focused on minimizing their burn rate and finding new sources of financing, all while trying to successfully navigate their programs through clinical development and regulatory approval. ... Browse the employee job titles on

  • A4P Bio Consulting Ltd

    A4P Bio Consulting Ltd. As experts in biomarkers, bioanalysis, pharmacokinetics, logistics and quality systems management A4P deliver scientifically robust, regulatory compliant, cost effective and value added solutions for the global life

  • Training the next generation of biotech leaders

    The £12m  Future Targeted Manufacturing Healthcare Hub is addressing manufacturing, business and regulatory hurdles in order to ensure new targeted innovations can be manufactured at a cost that is affordable to

More from PMHub
Approximately 3 fully matching, plus 170 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
IGNIFI

We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...

Latest intelligence

The gene therapy revolution
Gene therapies are bringing new hope for many people with diseases caused by genetic disorders...
PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...

Infographics